The global 3D Medical Imaging Devices market gathered revenue around USD 14.9 Billion in 2020 and market is set to grow USD 24.7 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 8.2% during the prediction period 2021 to 2027.
Growth Factors:
The global geriatric population coupled with the increase in cases of road traffic accidents are expected to drive the growth. Moreover, advancements in 3D imaging technology and investments by government and private organizations are other prime factors propelling the market.
According to a the United Nations (UN) report published in 2020, people aged 65 and above accounted for approximately 17.0% of the total global population. This number is growing at the rate of 5.0% annually. The geriatric population is more prone to musculoskeletal diseases and joint problems. Osteoarthritis is the most common problem for old age people of more than 65 years and is accompanied by increased mortality, and decreased quality of life. The global rise in incidence of chronic and life-threatening diseases are the major drivers for the market.
The emergence of automated 3D imaging scanners and on-going R&D development in contrast agents used for 3D imaging is also expected to propel the market growth. For instance, in July 2019, GE Healthcare introduced ready to drink the oral solution, Omnipaque (Iohexol) in the U.S. The solution acts as a contrast media and aids in visualization in the gastrointestinal tract.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the 3D Medical Imaging Devices market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global 3D Medical Imaging Devices market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 24.7 Billion by 2027 |
Growth Rate | CAGR of 8.2% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Historic Data | 2017 to 2020 |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Segments Covered | Device type, application, solution And Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Siemens Healthineers; Esaote SpA; Koninklijke Philips N.V.; GE Healthcare Ltd.; Canon Medical Systems; Hitachi Medical Systems; Shimadzu Corporation; DigiRad Corporation; Del Medical Systems Inc.. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
3D Medical Imaging Devices market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). North America, followed by Europe, collectively accounted for more than 63%market share in 2020. The growth of the North America region is attributed to the higher purchasing power of the healthcare settings, such as hospitals, long term care centers, and advanced specialty centers. Moreover, well established healthcare infrastructure compared to developing regions coupled with favorable reimbursement scenario is anticipated to bode well for regional growth during the forecast period.
Asia Pacific is estimated to exhibit significant growth by 2027 driven by improving healthcare infrastructure and rising medical tourism. However, the high cost of 3D medical imaging devices and low adoption rate are some of the factors hindering the growth of the regional market.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the 3D Medical Imaging Devices Market include: Siemens Healthineers; Esaote SpA; Koninklijke Philips N.V.; GE Healthcare Ltd.; Canon Medical Systems; Hitachi Medical Systems; Shimadzu Corporation; DigiRad Corporation; Del Medical Systems Inc.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the 3D Medical Imaging Devices market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the 3D Medical Imaging Devices market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the 3D Medical Imaging Devices markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in 3D Medical Imaging Devices market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global 3D Medical Imaging Devices Market, By Device Type
7.1. 3D Medical Imaging Devices Market, By Device Type, 2021-2027
7.1.1. X-ray Devices
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. CT
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Ultrasound Systems
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. MRI
7.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global 3D Medical Imaging Devices Market, By Application
8.1. 3D Medical Imaging Devices Market, By Application, 2021-2027
8.1.1. Oncology
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Cardiology
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Cardiology
8.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global 3D Medical Imaging Devices Market, By Solution
9.1. 3D Medical Imaging Devices Market, By Solution, 2021-2027
9.1.1. 3D Scanning
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. 3D Rendering
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. 3D Modeling
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global 3D Medical Imaging Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.1.2. Market Revenue and Forecast, By Application (2016-2027)
10.1.3. Market Revenue and Forecast, By Solution (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.1.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.1.4.3. Market Revenue and Forecast, By Solution (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.1.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.1.5.3. Market Revenue and Forecast, By Solution (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.2.2. Market Revenue and Forecast, By Application (2016-2027)
10.2.3. Market Revenue and Forecast, By Solution (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.2.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.2.4.3. Market Revenue and Forecast, By Solution (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.2.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.2.5.3. Market Revenue and Forecast, By Solution (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.2.6.2. Market Revenue and Forecast, By Application (2016-2027)
10.2.6.3. Market Revenue and Forecast, By Solution (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.2.7.2. Market Revenue and Forecast, By Application (2016-2027)
10.2.7.3. Market Revenue and Forecast, By Solution (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.3.2. Market Revenue and Forecast, By Application (2016-2027)
10.3.3. Market Revenue and Forecast, By Solution (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.3.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.3.4.3. Market Revenue and Forecast, By Solution (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.3.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.3.5.3. Market Revenue and Forecast, By Solution (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.3.6.2. Market Revenue and Forecast, By Application (2016-2027)
10.3.6.3. Market Revenue and Forecast, By Solution (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.3.7.2. Market Revenue and Forecast, By Application (2016-2027)
10.3.7.3. Market Revenue and Forecast, By Solution (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.4.3. Market Revenue and Forecast, By Solution (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.4.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.4.4.3. Market Revenue and Forecast, By Solution (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.4.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.4.5.3. Market Revenue and Forecast, By Solution (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.4.6.2. Market Revenue and Forecast, By Application (2016-2027)
10.4.6.3. Market Revenue and Forecast, By Solution (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.4.7.2. Market Revenue and Forecast, By Application (2016-2027)
10.4.7.3. Market Revenue and Forecast, By Solution (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.5.3. Market Revenue and Forecast, By Solution (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.5.4.2. Market Revenue and Forecast, By Application (2016-2027)
10.5.4.3. Market Revenue and Forecast, By Solution (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Device Type (2016-2027)
10.5.5.2. Market Revenue and Forecast, By Application (2016-2027)
10.5.5.3. Market Revenue and Forecast, By Solution (2016-2027)
Chapter 11. Company Profiles
11.1. Siemens Healthineers
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Esaote SpA
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Koninklijke Philips N.V.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. GE Healthcare Ltd
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Canon Medical Systems
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Hitachi Medical Systems
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Shimadzu Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. DigiRad Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Del Medical Systems Inc
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms